Skip to main content
Terug
Watch Compare

SERA PROGNOSTICS, INC.

Datakwaliteit: 100%
SERA
Nasdaq Services Health Services
€ 2,15
▼ € 0,07 (-3,15%)
Marktkapitalisatie: 84,16 M
Prijs
€ 2,15
Marktkapitalisatie
84,16 M
Dagbereik
€ 2,13 — € 2,30
52-Weeksbereik
€ 1,37 — € 4,09
Volume
17.335
Openen € 2,16
50D / 200D Gem.
€ 2,31
6,99% below
50D / 200D Gem.
€ 2,85
24,66% below

Quick Summary

Belangrijkste Punten

Revenue declined -0,31% annually over 5 years
Negative free cash flow of -26,35 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 5,50%
Capital intensive — 896,30% of revenue goes to capex

Groei

Revenue Growth (5Y)
-0,31%
Onder sectorgemiddelde (4,21%)
Revenue (1Y)5,19%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-37,47%
Onder sectorgemiddelde (-15,74%)
ROIC-33,37%
Net Margin-39417,28%
Op. Margin-45066,67%

Veiligheid

Debt / Equity
N/A
Current Ratio1,89
Interest Coverage-4056,00

Waardering

PE (TTM)
-2,64
Onder sectorgemiddelde (-1,17)
P/B Ratio1,02
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Services sector mediaan (502 peers)
Metriek Aandeel Sector Mediaan
P/E -2,6 -1,2
P/B 1,0 1,4
ROE % -37,5 -15,7
Net Margin % -39417,3 -18,3
Rev Growth 5Y % -0,3 4,2
D/E — 0,4

ETFs Holding This Stock

AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0,00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 5,19% Revenue Growth (3Y) -48,55%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -0,31% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 81.000,0 Net Income (TTM) -31,93 M
ROE -37,47% ROA -29,03%
Gross Margin N/A Operating Margin -45066,67%
Net Margin -39417,28% Free Cash Flow (TTM) -26,35 M
ROIC -33,37% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1,89
Interest Coverage -4056,00 Asset Turnover 0,00
Working Capital 20,99 M Tangible Book Value 81,24 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2,64 Forward P/E N/A
P/B Ratio 1,02 P/S Ratio 1039,00
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -31,31%
Market Cap 84,16 M Enterprise Value 80,08 M
Per Share
EPS (Diluted TTM) -0,67 Revenue / Share 0,00
FCF / Share -0,67 OCF / Share -0,65
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 896,30% FCF Conversion 82,53%
SBC-Adj. FCF -32,12 M Growth Momentum 5,50

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 81.000,0 77.000,0 306.000,0 268.000,0 82.000,0
Net Income -31,93 M -32,90 M -36,24 M -44,19 M -35,01 M
EPS (Diluted) -0,67 -0,99 -1,16 -1,43 -2,33
Gross Profit — — — — —
Operating Income -36,50 M -36,64 M -39,82 M -45,65 M -35,40 M
EBITDA — — — — —
R&D Expenses 13,17 M 14,73 M 15,23 M 14,24 M 11,02 M
SG&A Expenses — — — — —
D&A 940.000,0 833.000,0 900.000,0 756.000,0 659.000,0
Interest Expense 9.000,0 28.000,0 — — —
Income Tax 0,0 0,0 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 101,93 M 72,58 M 95,44 M 116,33 M 147,03 M
Total Liabilities 26,53 M 24,77 M 25,28 M 17,39 M 8,47 M
Shareholders' Equity 75,41 M 47,80 M 70,16 M 98,94 M 138,56 M
Total Debt — — — — —
Cash & Equivalents 3,94 M 4,04 M 3,88 M 29,88 M 58,93 M
Current Assets 40,77 M 47,60 M 61,34 M 90,13 M 110,25 M
Current Liabilities 24,19 M 24,77 M 24,44 M 15,54 M 8,41 M